NCT00408512View on ClinicalTrials.gov

Pharmacosurveillance and Pharmacogenetics of First-line Diuretics in Hypertension: The StayOnDiur Study

PHASE4CompletedINTERVENTIONAL

Enrollment

2,500

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

December 31, 2009

Study Completion Date

March 31, 2010

Conditions

Essential Hypertension

Interventions

DRUG

thiazides

Up to 25 mg per day

PROCEDURE

Non thiazidic treatment

Amximum tolerated dosage as indicated from the label

Trial Locations (1)

80131

Ambulatorio Ipertensione e Unità Coronarica Federico II University, Napoli

All Listed Sponsors

collaborator

Agenzia Italiana del Farmaco

OTHER_GOV

lead

Federico II University

OTHER

NCT00408512 - Pharmacosurveillance and Pharmacogenetics of First-line Diuretics in Hypertension: The StayOnDiur Study | Biotech Hunter | Biotech Hunter